[PLX] QoQ Quarter Result on 30-Jun-2011 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Aug-2011
Financial Year
2011
Quarter
30-Jun-2011 [#Q2]
Profit Trend
QoQ- -170.96%
YoY- -36.33%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Revenue 3,728 2,362 1,132 764 6,000 1,176 3,184 11.07%
PBT 0 968 0 179 -5,052 22,414 0 -
Tax -161 -27,616 108 20,699 0 -20,470 -374 -42.95%
NP -5,904 -8,913 -8,875 -13,689 -5,052 -8,528 -2,474 78.48%
Tax Rate - 2,852.89% - -11,563.69% - 91.33% - -
Total Cost 9,632 11,275 10,007 14,453 11,052 9,704 5,658 42.52%
Ratio Analysis
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
NP Margin -158.37 -377.35 -784.01 -1,791.75 -84.20 -725.17 -77.70 60.68%
Per Share
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
EPS -0.07 -1.01 -0.10 -0.16 -0.06 -1.04 -0.03 75.83%
EPS Diluted -0.07 -1.01 -0.10 -0.16 -0.06 -1.04 -0.03 75.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.